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Background: Accounts of evidence are vital to evaluate and reproduce scientific
findings and integrate data on an informed basis. Currently, such accounts are often
inadequate, unstandardized and inaccessible for computational knowledge
engineering even though computational technologies, among them those of the
semantic web, are ever more employed to represent, disseminate and integrate
biomedical data and knowledge.
Results: We present SEE (Semantic EvidencE), an RDF/OWL based approach for
detailed representation of evidence in terms of the argumentative structure of the
supporting background for claims even in complex settings. We derive design
principles and identify minimal components for the representation of evidence. We
specify the Reasoning and Discourse Ontology (RDO), an OWL representation of the
model of scientific claims, their subjects, their provenance and their argumentative
relations underlying the SEE approach. We demonstrate the application of SEE and
illustrate its design patterns in a case study by providing an expressive account of
the evidence for certain claims regarding the isolation of the enzyme glutamine
synthetase.
Conclusions: SEE is suited to provide coherent and computationally accessible
representations of evidence-related information such as the materials, methods,
assumptions, reasoning and information sources used to establish a scientific finding
by adopting a consistently claim-based perspective on scientific results and their
evidence. SEE allows for extensible evidence representations, in which the level of
detail can be adjusted and which can be extended as needed. It supports
representation of arbitrary many consecutive layers of interpretation and attribution
and different evaluations of the same data. SEE and its underlying model could be a
valuable component in a variety of use cases that require careful representation or
examination of evidence for data presented on the semantic web or in other
formats.
Bölling et al. Journal of Biomedical Semantics 2014, 5(Suppl 1):S1
http://www.jbiomedsem.com/content/5/S1/S1 JOURNAL OF
BIOMEDICAL SEMANTICS
© 2014 Bölling et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Scientific evidence, as a concept, can be defined as information that is relevant to assess
the likelihood that a particular scientific idea is correct. Representation of the corre-
sponding evidence is therefore key to evaluating hypotheses and assessing claims con-
tained in scientific articles, databases or any other repository of scientific information.
Biomedical knowledge is often highly context-dependent and based on evidence obtained
from the skilful combination and evaluation of individual results, involving, among other
aspects, a range of model organisms, diverse experimental and computational techniques,
different forms of interpretation, and various inference schemes. Consequently, all those
aspects - the materials, methods and information sources used, the observations made,
the reasoning employed and the context-specific assumptions made - are important for
comprehensive evidence accounts. Likewise, when data, often from disparate sources, is
integrated to study complex biological systems an account of the evidence that was used
to infer a model’s properties and those of and among its components is critical for cor-
rect and transparent understanding of that model.
Scientific findings are now routinely published as resources on the World Wide
Web. Besides electronic versions of natural language texts more and more information
from both new and legacy sources becomes available through databases [1] and web
services [2] which provide through structured formats and interfaces consolidated
views of and programmatic access to biomedical data. Semantic web technologies and
standards in particular offer by virtue of their well-defined semantics and broad applic-
ability potent means for the computational integration and analysis of biomedical data
from heterogeneous and distributed sources on a large scale [3-5]. Accordingly, the
Resource Description Framework (RDF, [6]) is increasingly employed to represent and
disseminate new and legacy biomedical data [7,8] and biomedical ontologies specified
in the Web Ontology Language (OWL, [9]) are being developed to encode domain-
specific knowledge and annotate data from biomedical investigations [10-12]. As with
any other means for communicating scientific results, findings encoded in semantic
web formats need to be accompanied by an account of how they have been established
to evaluate their relevance. Towards this end different models, tools and methods have
been proposed: for representing and evaluating research hypotheses [13,14], contextua-
lization [15], models of discourse [16], of argument [17], extended means for annota-
tion [18,19], or specific container formats [20]. There is, however, currently no
dedicated model supporting a coherent, extensible and semantic-web compatible repre-
sentation of all those aspects routinely considered by a researcher inspecting the
evidence for a given scientific finding, i.e. a representation of (i) the experimental and
computational methods and settings that were used to establish the observational
results and process the data, (ii) the reasoning including additional findings and
assumptions used to infer the result in question, and (iii) information sources and
agents through which the corresponding views were communicated and propagated.
Here we introduce SEE (Semantic EvidencE), an RDF/OWL based approach for pro-
viding detailed, extensible and computationally accessible accounts of evidence even in
complex settings. SEE is designed to enable the fabric of observations, methods,
assumptions, and inferences examined by researchers to evaluate the evidence for a
claim to be formally represented along with their sources using semantic web techni-
ques. Evidence is captured in terms of the argumentative structure of the supporting
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background for a claim i.e., by a coherent representation of claims, of the entities the
claims are about, of the argumentative relations between the claims and of claim pro-
venance. SEE accommodates nested layers of interpretation and attribution and different
evaluations based on the same data. We demonstrate its application in a case study that is
typical for the task of collecting, representing and evaluating evidence for systems biology
approaches such as genome-scale metabolic network reconstruction by providing an
expressive account of evidence for the location of the enzyme glutamine synthetase.
Results
Overview of the SEE approach
The SEE approach for representing evidence consists of providing (i) a formal representa-
tion of scientific claims, their provenance and the argumentative structure used to justify
them by other claims, (ii) a formal representation of claim content and (iii) a coherent
integration of the two. SEE relies on an abstract model for the representation of claims,
provenance and argumentative structure specified in the Reasoning and Discourse
Ontology (RDO), a lightweight OWL vocabulary developed for this purpose. Claim con-
tent e.g., what is claimed regarding the properties of biological entities or the results and
methods of an investigation is represented in RDF graphs by using appropriately defined
semantic web resources and design patterns which as a best practice should, if possible, be
re-used from existing domain ontologies. The connection between claims as representa-
tional primitives and their content relies on named RDF graphs [21] which enable pointing
to collections of RDF-triples or OWL-axioms serialized as such.
After outlining general requirements and design principles for representation of evi-
dence we describe the RDO. We then demonstrate the application and design patterns of
the SEE approach in a case study generating an expressive representation of evidence
reported in the literature for the location of the enzyme glutamine synthetase.
Deriving design principles and requirements for representation of evidence
We posit two design principles for the representation of evidence and explain their
rationale in the following:
DP1: Representation of evidence amounts to representation of claims and argumentative
structure.
DP2: Evidence relations in the sense of “A is evidence for B” obtain between the
things being claimed.
Accounts of evidence are directed towards the justification of scientific claims. The SEE
approach is based on the notion that scientific claims put forward possible, more or less
likely scenarios and outcomes - states of affairs [22] - as being accurate descriptions of a
subject of scientific inquiry. Something is evidence for a certain state of affairs, if and only
if it gives reason to believe that this state of affairs in fact obtains [23]. A pairing of evi-
dence and what it is claimed to be evidence for therefore corresponds to the set of pre-
mises and the conclusion of an argument in which the truth of the premises alleges to
give reason to believe the conclusion is true. Therefore the evidence used by authors or
agents to justify a claim, possibly using further unstated background assumptions, can be
mirrored by an argumentative structure having the claim as its conclusion. Typically, what
is used to justify the authors conclusions within this argumentative structure are claims in
themselves accepted as true on the basis of observations or inferences of the same or of
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other investigators. SEE, therefore, models evidence relations in the sense of “A is evidence
for B” specifically as relations between claims.
We derive two additional requirements:
DP3: A researcher’s assessment of the evidence for a finding usually includes evaluation
of which materials and methods were used, what kind of data was obtained and which
properties were observed, inferred or assumed to establish the finding. Consequently, a
representation of the materials, methods, data items and other elements forming the
subject of a claim should be part of a computationally accessible evidence representation.
In RDF and OWL the subject of a claim, a state of affairs, must be expressed, using appro-
priately defined resources, as (one or more) triples and axioms, respectively. It follows
then, in accordance with DP2 that in an RDF/OWL-based representation of evidence that
includes claim subjects the representation of evidential relationships should operate
between claim subject representations, i.e. between sets of RDF-triples and/or
OWL-axioms.
DP4: Representation of claims and hence representation of evidence must take into
account claim provenance, in particular through which source and by which agents the
claims were made. Knowing which agent made the claim is crucial for evaluating inde-
pendence and reproducibility. Tracking the original source of a claim provides a natural
reference point for all subsequent representations of the claim and its supporting back-
ground and for re-evaluation of the claim within the original context in which it was
communicated.
We therefore identify as minimal components for modelling evidence elements repre-
senting (i) scientific claims and the argumentative structure used to justify them by other
claims, (ii) the subjects of the claims i.e. that what is claimed with regard to a subject of
inquiry, (iii) the agents making the claims and arguments, (iv) the sources in which claims
were originally made e.g., the original scientific articles or database records.
Reasoning and Discourse Ontology (RDO)
Based on the foregoing we developed an abstract model for representation of evidence in
terms of claims, their argumentative structure and their provenance. It is specified here as
the Reasoning and Discourse Ontology (RDO) using the Web Ontology Language (OWL).
This section outlines the core classes and properties of RDO. Full, formal specification of
all RDO constructs is provided in the ontology file provided as additional file 1.
The typical scenario that underlies the constructs defined in RDO is the following:
Agents (e.g., individual scientists) make claims on particular occasions (e.g., as authors
of a published scientific article) about a subject of inquiry. The subject of the claim - i.
e. what is claimed - is communicated in some linguistic form, often as part of a more
comprehensive report (e.g., a scientific article) authored by the agents. Claims are
usually justified by other claims the subject of which has been accepted as true, usually
on the basis of yet other claims. RDO (Figure 1) rests on the distinction of a claim, its
subject and the linguistic form in which this subject is communicated and is centered
around the concept of an assertion [24]: instances of the class assertion (courier
typeface denotes OWL classes, courier in italics denotes OWL properties)
represent particular claims made by particular agents on a particular occasion that a
particular proposition, the subject of the claim, is true. Propositions, in our model, are
represented by the class proposition and taken to represent the semantic content
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of contextualized lexical entities formulated in some natural or artificial language [25].
The lexical entities by which the subject of a claim and propositions and reports in
general are formulated are represented using the class text. Further core classes are
report representing accounts intended to accurately describe an event or situation.
Thus, scientific journal articles or database records as typical sources of assertions are
examples of a rdo:report. Agent is used to represent individual persons, corporate
bodies or information processing devices as roleplayers in the creation of reports or
assertions. RDO specifies various properties to represent the relations between
instances of these classes (Figure 1). In particular, argumentative structure is captured
by the property is inferred from which relates an instance of assertion to
another if and only if the former is, directly or indirectly, inferred from the latter (and
possibly other premises).
Application: representation and evaluation of evidence for a source of glutamine
synthetase
Introducing the case study
We applied SEE to generate a computationally accessible, expressive and extensible
account of evidence gathered in the literature regarding a claimed source of the enzyme
glutamine synthetase (GS). We have chosen this particular test case because obtaining reli-
able information on location of enzyme activities is a subject area of particular importance
for systems biology approaches such as the reconstruction of cell-type specific [26] or
organism-level [27] metabolic networks. Furthermore, it embodies the typical task of
acquiring knowledge on a subject of inquiry by extracting and combining evidence from
different sources.
Figure 1 Core classes and properties in RDO. Boxes denote labelled classes, arrows denote labelled
properties, direction of arrows denotes property domains and ranges. Asterisk: property has domain and
range-specific sub-properties. The color code used here is also used in subsequent figures.
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Starting point is our evaluation of a scientific journal article [28] (referred to as ‘Meister
1985’ in the following) authored by Alton Meister which asserts in the second paragraph
of the text, among other things, that the enzyme glutamine synthetase (GS) was isolated
from rat liver. This assertion is based, by way of citation, on the contents of another article
by Tate, Leu and Meister [29] (referred to as ‘Tate 1972’ in the following). In Tate 1972
the isolation of GS from rat liver is reported. The finding is reported to be based on an
investigation which involved, among other things, extraction of rat livers, protein purifica-
tion and g-glutamyl hydroxamate synthesis (g-GHS) assays. In the following we show how
this context is formalized using the SEE approach to yield a detailed formal account of the
evidence presented through these articles for rat liver as source of GS. In doing so, we
illustrate various design patterns used in SEE for representing the relevant items. For
clarity assertion instances will be indexed as A1, A2, and so forth.
Representing the evidence
Figure 2 shows how the assertion from Meister 1985 that GS was isolated from rat
liver is represented using RDO, exemplifying the design pattern used to represent the
relations between a particular assertion and its subject and provenance: The article
Figure 2 Representation of assertions with subject and provenance. Assertion instances are
related to proposition instances representing the subject of the assertion by asserts, to the agents
making the assertion by is_assertion_made_by and to the reports in which they are made by
is_assertion_made_in. See text for additional relations among assertions, agents, reports and textual
representations. Assertion and proposition labels reflect the graph representation of assertion subjects (see
text). Color code of assertion and proposition labels indicates the structured representation of assertion
subjects (yellow: class, blue italics: property, red: Manchester syntax restriction keyword). Circle shows the
index by which the assertion is referred to in the text.
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itself, Meister 1985, is classified as instance of report annotated with a uniform
resource locator (URL) providing its digital representation. The second paragraph of
Meister 1985 constitutes a report_part. It is expressed as the English language text
as which it is written and which is represented as an instance of text. The original
text is linked to it via the data property has_lexical_structure. Meister’s claim
that glutamine synthetase was isolated from rat liver contained in this paragraph is
represented by an instance of assertion (A1) labelled as ‘! some GS-enzyme isolated
from some rat liver ! AM’ to indicate the assertion subject in a concise, human read-
able manner (formalization of assertion subjects is described below). A1 is related to a
corresponding instance of proposition identifying the subject of the claim, to an
instance of agent representing Alton Meister, and to said report part by the prop-
erties asserts, is_assertion_made_by and is_assertion_made_in,
respectively.
Claims which reiterate previous findings are represented as assertions on the same sub-
ject made by the respective agents. Formally, the reiterating claim is represented as an
assertion instance which is linked to the source assertions by is_directly_in-
ferred_from and linked to the same proposition instance as the source assertions
by asserts. Each assertion can be linked to its corresponding agents and reports. Appli-
cation of this design pattern to our case study is shown in Figure 3: The fact that Meisters
assertion (A1) reiterates what Tate & co-workers have asserted on the isolation of GS
from rat liver (A2), is represented by a relation of the former to the latter via is_direc-
tly_inferred_from and by sharing the same proposition instance via asserts.
The argumentative structure within and across the publications is represented as a
series of assertion instances and is_directly_inferred_from relations with
additional links to represent assertion subjects and provenance (Figure 4). The
assertion instances linked to A2 reflect the results and the reasoning of the authors
at various steps of their investigation based on a careful analysis of the internal argu-
mentative structure of Tate 1972. Specifically, Tate et al.’s main conclusion that GS-
enzyme was isolated from rat liver (A2) is essentially based on asserting that (A3)
there is a biological sample (labelled ‘sample-1’) which has GS-activity, that (A4) any
GS-activity is borne by some GS-enzyme and that (A5) sample-1 was isolated from
some rat liver (precise definitions for GS-enzyme, GS-activity in the context of the
case study are detailed in additional file 2). The joint use of A3, A4 and A5 to infer A2
Figure 3 Representation of claims which reiterate previous findings. The fact that Meisters assertion
(A1) reiterates what Tate & co-workers have asserted on the isolation of GS from rat liver (A2), is
represented by a relation of the former to the latter via is_directly_inferred_from and by
sharing the same proposition instance via asserts. Each assertion instance is linked to its
corresponding agents and reports. Color code as in figure 1.
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is made explicit by using the has_conjunctive_part property to link them to the
same composite assertion instance which in turn is related to A2 using the
is_directly_inferred_from property. This pattern is used whenever an asser-
tion is inferred from more than one premise. A3, the assertion that sample-1 has GS-
activity is justified in turn by asserting that (A6) it was input to a particular assay
(labelled assay-1), that (A7) this assay produced a particular result, data item 1, and
that (A8) this data item is a measurement of some GS-activity. A8, in turn, is justified
by asserting that (A9) the data item is output of assay-1, that (A10) this assay was a g-
GHS assay, and that (A11 & A12) this type of assay is suited to measure GS-activity.
Some assertions are not further justified, either because they reflect factual descriptions
in Tate 1972 (A9, A10), represent general assumptions of the authors (A11) or are
expressions of terminological domain knowledge (A12, A4). A5 exhibits a similar justi-
fication trail, as shown in Figure 4. Full, formal representation of the argumentative
structure for the test case is provided in additional file 2.
The prevalent pattern in SEE for recording individual and logically relevant steps of an
investigation is for any such step to link its outcomes (data or material), the techniques
used to produce these outcomes, and their objectives as exemplified in the composite
assertions comprising assertions A9-A12 and A15-A20 (Figure 4). In A9-A12, for example,
the experimental process type (g-GHS assay) is linked to the objective of its application
(GS-activity measurement) and in turn to the quality that is intended to be determined
(GS-activity). Generally, the relations between these ontologically different entities are not
Figure 4 Representation of argumentative structure within and across publications. The
argumentative structure used to justify Meister’s claim on the isolation of GS from rat liver (A1) is
represented as a series of assertion instances linked by is_directly inferred_from relations.
Dashed line separates assertions made in Meister 1985 and Tate 1972. Dashed-dot boxes indicate composite
assertions with their component assertions placed inside signifying the has_conjunctive_part
relations. Author initials tags of the assertions made by Tate et al. are omitted, as are links to propositions,
reports, authors and texts. Color code as in figure 1.
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trivial and not one-to-one (one objective can consist of the determination of several quali-
ties recognized in a scientific domain, a certain quality can be the subject of inquiry in sev-
eral objectives). However, in this particular case the objective and quality are narrowly
defined and directly correlated.
Representation of assertion subjects
The representation of argumentative structure and claim provenance as an interrelated set
of assertion instances described so far is complemented by a structured representation
of what is asserted in each assertion, the assertion subject. To this end each assertion
instance is linked to a corresponding proposition instance the IRI (Internationalized
Resource Identifier) of which identifies a named RDF graph. This graph provides a struc-
tured representation of the assertion subject using appropriately defined resources (Figure
5). This setup enables querying the elements forming the assertion subject. In assertion
A10, shown in Figure 5 as an example, it is asserted by Tate and co-workers that the parti-
cular assay they performed was a g-GHS assay. The representation of this statement as a
graph identified by the IRI of the proposition instance linked to the assertion
instance representing A10 enables to access the entities A10 is about: the particular assay,
its asserted type, and the typing relation itself. Full specification of all propositions as
named graphs in the context of the case study is provided in additional file 3.
Figure 5 Representation of assertion subjects as named graphs. In SEE structured, queryable
representations of assertion subjects are provided as named graphs. A) The structured representation of the
subject of an assertion can be accessed as the RDF graph identified by the IRI of the proposition instance
related by the asserts property to the assertion instance representing the assertion. B) Structured
representation of the subject of assertion A10 asserting that the particular assay performed by Tate et al.
(:assay-1) was a g-GHS assay (:gamma_ghs_assay). C) TriG representation of the graph shown in B.
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To generate the graph representations of the assertion subjects, the natural language
expressions of the assertions identified in the Meister 1985 and Tate 1972 reports were for-
malized in RDF using appropriately defined resources (see additional files 2, 3 and 4). Most
assertion subjects could be formalized in a straightforward manner applying OWL 2 RDF-
based semantics [30]. The principal claim that “glutamine synthetase was isolated from rat
liver” which is the common subject of assertions A1 and A2 was formalized in RDF by
instantiating the class gs_enzyme and is_isolated_from some rat_liver (shown
as :proposition-1 in additional file 3). This exemplifies instantiation of the OWL-class
(A and related_to some B) as a design pattern for formalization of statements which
can, in natural language, be represented in the form “some A related to some B” (A and B
denoting OWL-classes used to represent the types A and B, respectively and related_to
denoting an OWL-property used to represent the relation among some of their instances).
Labels of assertion and corresponding proposition instances are directly
derived from the graph representation of the assertion subject (see methods section).
In particular, the label “some A related_to some B“ is used for proposition
instances that represent statements of the form “some A related to some B” by applying
the design pattern described above.
Representing consecutive layers of interpretation and own conclusions
We use the test case to specify additional design patterns to represent activity of a
curator or generally of a third party evaluating a scientific report. Our representation
of the evidence in the Meister 1985 and Tate 1972 reports is the result of the interpre-
tation by another agent (Christian Bölling - CB). This can be explicitly represented in
SEE using its familiar design pattern for propositions and assertions. For example, the
claim that Tate et al. indeed assert that the assay they performed was a g-GHS assay in
their 1972 publication can be represented as an assertion instance in its own right,
made by another agent, CB (Figure 6). This pattern allows for representing arbitrary
many consecutive layers of interpretation or attribution.
So far the presented account consists of assertions attributed to the authors of the
Meister 1985 and Tate 1972 reports, i.e. a representation of what these authors assert.
SEE also provides the resources to append own conclusions. For example, an agent, CB,
could upon evaluation of the claims made by Tate et al. conclude for himself that GS
was indeed isolated from rat liver. This is represented as an assertion instance in its
own right (A30, labelled ‘! some GS-enzyme isolated from some rat liver ! CB’). It is
linked to the corresponding proposition via asserts and the assertions made by Tate
et al. via is_directly_inferred_from. We describe two semantically different pat-
terns to make this connection. In pattern 1 assertion A30 is linked to assertion A2
(Figure 7). In pattern 2 (Figure 8) A30 is linked to a new composite assertion that
involves two more curator assertions (A31, A32) and A4 as a representation of termino-
logical domain knowledge. A31 and A32 are linked by is_directly_inferred_-
from to composite assertions reflecting factual descriptions of data and procedures
given in Tate 1972. There is a subtle, yet important difference in meaning between these
two representations. In pattern 1 CB’s conclusion is based on Tate et al.’s assertion on
the same subject, i.e., it is based on the author statement itself and does not necessarily
imply an affirmation of how Tate et al. reached their conclusion. In pattern 2 the curator
inference is based on factual descriptions in Tate 1972, i.e., it affirms the conclusions of
Tate et al. as own conclusions on the basis of the reported experimental results.
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Evaluation of a given set of data might also lead to conclusions different from those
of the authors. Such alternative interpretations can be represented using SEE. For
example, one might dispute that g-GHS assays are suited to measure GS-activity (EC
6.3.1.2). The g-GHS assay works by measuring the formation of L-g-glutamyl hydro-
xamate rather than glutamine [31]. Tate et al. assert as the objective of its application
GS-activity measurement, accepting the formation of the hydroxamate under the
conditions of the assay as a proxy for the formation of glutamine and the actual reac-
tion mechanism. Assertion A11 using the property achieves_objective reflects
this acceptance by Tate et al.. Alternatively, a third party could assert that g-GHS
assays merely achieve the less specific objective of measuring g-glutamyl transferase
(GGT) activity (EC 2.3.2.2) (Figure 9, assertion A45). In this case the data reported
by Tate et al. can still be used to infer that rat liver is a source of GGT-enzyme
(Figure 9, assertion A40).
Figure 6 Representation of consecutive layers of interpretation. Consecutive layers of interpretation
can be represented as assertions the subject of which is about other assertions. A) CB’s assertion that ‘Tate
and co-workers assert that assay-1 was a gamma-GHS assay in their 1972 report’ is represented as an
assertion instance linked to a proposition instance whose named graph representation relates the
assertion instance A10 to the Tate 1972 report via the is_assertion_made_in property. B) TriG
representation of the graph shown in A. In combination with the RDF dataset shown in Figure 5C this is
an example of a named graph referencing a named graph via the corresponding assertion and
proposition instances. Color code as in figure 1.
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Evaluating the test case evidence representation
The test case evidence representation that was created using the RDO constructs and
design patterns was evaluated in terms of its potential to answer, within the confines of
the case study, a list of competency questions reflecting different aspects of the evidence
a researcher investigating glutamine synthetase knowledge would be interested in:
Q1: Which locations of GS have been asserted?
Rat liver.
Q2: Where has rat liver GS been reported?
The Meister 1985 and Tate 1972 reports.
Q3: Do the assertions made in these reports pertain to independent observations?
No. Meister’s assertion is based on Tate et al.’s assertion. Moreover, some of the
authors of the two reports are identical.
Q4: Is there experimental evidence and where is it described?
Yes. In the Tate 1972 report.
Figure 7 Representation of curator activity: inference from author statement . The pattern to
represent inference from author statement is illustrated here by linking curator assertion A30 (shown in
bold) to assertion A2 of the Tate et al. argumentation signifying inference of A30 on the basis of an author
statement of Tate et al. on the same subject. Color code as in Figure 1.
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Q5: Which observations and techniques were used for establishing rat liver as GS source?
1. extraction of a protein sample from rat liver (technique: TLM purification)
2. that sample has GS-activity (technique: g-GHS assay)
Q6: Did Tate et al. really make these observations and conclusions? Who created this
account of their findings?
Christian Bölling.
Based on the SEE design patterns, these questions could be formulated as SPARQL
[32] queries and successfully answered (see additional file 5). In each of Q1-Q6 the
structured representation of assertion subjects as named graphs, besides the other SEE
design patterns, is used to identify assertions which are relevant to answer the query.
For answering Q1 assertions are identified whose subject’s graph representation
includes a graph pattern indicative for the isolation of GS from some location (Figure
10A). For answering Q3, pairs of assertions are identified whose subjects share the
same graph representation and where one is inferred from the other (Figure 10B).
Figure 8 Representation of curator activity: inference from experimental evidence. The pattern to
represent inference from evaluation of the reported experimental evidence, in contrast to inference based
on author statement (Figure 7), is illustrated here by linking curator assertion A30 to a new composite
assertion involving curator assertions A31 and A32. These are, in turn, linked to the composite assertions
A9-A12 and A15-A20, respectively. These composite assertions reflect data and procedures reported in Tate
1972. Taken together this graph therefore represents a curator conclusion (A30) based on the affirmative
outcome (A31, A32) of the evaluation of the data and procedures reported in Tate 1972. Note that A2, the
principal conclusion of Tate et al. is unrelated to the new composite assertion. Curator assertions and their
links to the Tate et al. argumentation are shown in bold. Color code as in Figure 1.
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The following evidence-related information can be queried exploiting property chains
and other axioms defined for the RDO constructs:
- all assertions which are directly or indirectly used to infer a given assertion
- all assertions made in a given report
- all assertions made by a given agent
- all assertions on the same subject
- all agents making assertions on a given subject
For the corresponding queries see additional file 5. As an example, in Figure 11 the
object property assertions inferred for assertion A1, Meister’s assertion that GS was
isolated from rat liver, are shown. These inferences, simply derived in Protégé 4 with
HermiT 1.3.8 as a reasoner include all assertions which A1 is directly or indirectly
inferred from and all reports and texts A1 is based on.
Discussion
SEE design
SEE offers a tangible interpretation of the concept of evidence in terms of the argu-
mentative structure of the supporting background for a claim. It rests on the
Figure 9 Representation of curator activity: alternative interpretations of reported data. Alternative
interpretations of reported data can be represented as assertions that are made by a third party and linked
to assertions reflecting factual descriptions of the reported data. Based on CB’s assertion that g-GHS assays
measure GGT activity (A45) - rather than GS-activity - it is inferred that GGT-enzyme has been isolated from
rat liver (A40). The corresponding inference chain relies on a number of new curator assertions (A41-A46)
and their combination into composite assertions but re-uses assertions on the quantitative data obtained
and the procedures conducted by Tate et al. Curator assertions and new inference links are shown in bold.
Color code as in Figure 1.
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Figure 10 Competency questions SPARQL queries. A) SPARQL query to identify all asserted locations of
GS (Q1). This query identifies patterns in which an assertion (_:q11) has a subject (_:q12) which includes a
graph pattern indicative for the isolation of GS from some location. B) SPARQL query to identify
dependency of assertions on the same subject. The query identifies assertions (_:q31, _:q33) which share
the same subject (?proposition) and are inferred from one another.
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disctinction between claims as such (assertion), their subjects (proposition) and the
linguistic form in which these subjects are communicated (text). As a consequence of
this design evidential relations (as in “A is evidence for B”) can be represented consis-
tently as relations between assertions. This means that statements of the form “this
dataset / experiment / publication / method is evidence for B” are regarded as figura-
tive expressions. Instead, the relation between a dataset, an experiment or a publication
and the state of affairs it is claimed to be evidence for is represented indirectly through
relations between assertions the subjects of which relate to the entities in question.
The advantage of this design is that it enables a coherent representation not only of
extensive argumentative networks but also of arbitrary many layers of consecutive
Figure 11 Inferred object property assertions. Inferred object property assertions for Meister’s assertion
that GS was isolated from rat liver (A1).
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interpretations and alternative evaluations of the same observations or information
sources. RDO offers clear, formally defined types and relations for representing claims,
their subjects, their linguistic representations, related information sources and agents
on the basis of well established concepts from epistemology and the philosophy of lan-
guage [22,24,25,33,34]. The case study examples suggest that the SEE design principles
and their implementation in RDO are capable of correctly representing, in a computa-
tionally accessible and coherent form, the entire ‘evidence trail’ for a claim needed to
evaluate its relevance including observational data, research techniques, assumptions
and information sources.
SEE represents argumentative structure at its foundational level of premises being
used to infer a conclusion using the is_directly_inferred_from property and
its transitive superproperty is_inferred_from. This allows for a coherent repre-
sentation of different argument forms and larger rhetorical structures which can be
mapped onto their underlying assertions.
SEE aims to capture arguments as they are presented in their sources rather than to
evaluate their quality or to categorize them. How conclusive an argument is will typi-
cally depend on agent background knowledge or application-dependent requirements.
The SEE design enables users to evaluate evidence according to their own, possibly
domain- and application-specific criteria.
SEE-based accounts could also be used alongside specified rules, or argument forms
considered as acceptable by individual researchers or within specific domains of
inquiry which could then be leveraged to automatically infer new assertions on the
basis of the already asserted information.
With regard to the extraction of assertion subjects and a specific argumentative
structure from a natural language text SEE relies in its current form on a heuristic
approach leveraging expert domain knowledge to identify assertions and formalize
them in OWL. As OWL is a subset of first order logic there may be statements from
natural or artificial languages which cannot directly be translated into OWL, constrain-
ing the formalization of assertion subjects in SEE. It is, however, not clear which actual
limitations arise from this theoretical constraint for the representation of evidence in
specific use cases. The test case presented here suggests that within a specified domain
of discourse, using appropriate constructs and design patterns, the relevant contents of
the statements made originally in a context-rich narrative format such as a scientific
journal article can be adequately formalized.
Formalization of natural language statements is an important prerequisite for compu-
tational approaches to data evaluation. For applications that can forego this need the
statements can be represented in their original form as texts or referenced by links to
the original information sources. Both are by default designed to be provided in SEE as
reference points for evaluation.
The presented design patterns make SEE-based accounts of evidence extensible. This
design is in line with the open world assumption on which RDF and OWL as knowledge
representation languages operate. The particular argumentative structure and level of
detail presented in the case study are based on heuristics reflecting domain-specific
requirements to understand how an enzyme was characterised. This representation can be
extended or shortened as required. For example, details on the protein purification process
performed by Tate et al. or indeed any other detail that becomes relevant for the
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evaluation of the presented evidence could be appended to the existing assertions. Like-
wise, as we have demonstrated, alternative views and conclusions can be accommodated.
On the other hand, for applications which only require information on claim provenance,
only the source publications of the main claims could be represented.
Evidence types
Evidence type schemes provide a useful shorthand categorization of research techni-
ques used to establish a claim. SEE could be aligned with any categorization of
research techniques and hence evidence type scheme to characterise the evidence for
an assertion. Essentially, SEE provides a platform to define custom, extensible evidence
types and apply them as needed. For example, the evidence for rat liver as a source of
GS in the test case could be characterised as “experimental evidence” as “based on a
direct assay” as “based on a g-GHS-assay” or as “based on a g-GHS assay, protein puri-
fication involving Sephadex chromatography, and samples from Sprague-Dawley rats”
depending on the level of accuracy desired.
The flexibility and extensibility of the SEE approach may also be useful to character-
ise evidence where several techniques have been combined to establish a scientific
result or evidence is characterised in combination with claim provenance. We illustrate
this with a comparison to the Gene Ontology (GO) evidence codes which are meant to
reflect the type of work or analysis described in the cited reference which supports the
GO term to gene product association [35]. GO evidence codes consist of a collection
of terms arranged in a hierarchical format. In this taxonomy the terms representing
justifications based on author statements (TAS, NAS) are unrelated to those representing
experimental techniques (EXP and child terms). Consequently, GO associations marked
as being made on the basis of an author statement are usually not qualified with respect
to how this author statement came about. In contrast, as demonstrated in the case
study, using SEE any author statement can be extensively qualified in terms of the
experimental evidence or other author statements it is directly or indirectly based on.
Use cases
Representations which use SEE or its underlying model could be productive in a variety
of use cases requiring careful examination or recording of evidence, e.g.,
- providing supporting background information for biomedical knowledge bases,
- creating digital abstracts of research publications,
- adding a claim-level perspective on research publications which could be used by
publishers, in bibliographic databases and in personal bibliography managers,
- providing open linked data which can be integrated on an informed basis using
varying, application specific evidence criteria.
Related and future work
The SWAN biomedical discourse ontology [16] developed in the context of the
Semantic Web Applications in Neuromedicine (SWAN) project offers a formal model
of scientific discourse based on two different classes of statements; swan:hypothesis
and swan:claim. Claim subjects are to be represented in natural language and the reso-
lution of their supporting background is confined to the document level. The
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Annotation Ontology (AO) [18] has been implied as a means to provide formalized
accounts of claims and their supporting background conceptualized as annotations and
document parts, respectively. While it is possible in this way to relate individual ontol-
ogy terms to parts of documents, the AO semantics and use cases suggest that its
main application area is representation and support of annotations of documents
rather than representation and evaluation of extensive, possibly nested, networks of
claims. Nanopublications have been proposed as a container format to encode and
publish individual assertions using Semantic Web and Linked Data principles [36].
Ideas to include basic evidence-related information such as references to an informa-
tion source or a research technique in the provenance portion of a nanopublication
have been sketched [20] but appear not to be formally defined as part of a normative
specification. The recently drafted micropublications model [37] shares scope with SEE
with regard to the representation of extensively justified claims. The models use struc-
turally different conceptualizations which lead to different design patterns for repre-
senting claims, their provenance, and the evidence for a claim (see additional file 6).
The central focus of the SEE approach is to provide a formalized account of evidence as
claims, their subjects and their argumentative structure using clearly defined concepts and
semantics. From this perspective SEE and related works may be seen as complementary:
The basic notion of a report part in RDO could be complemented with AO’s rich set of
selectors as pointers to various elements of scientific reports. Recent alignment of the
Citation Typing Ontology (CiTO) and SWAN produced a consolidated set of constructs
to characterise bibliographic references [38]. Potentially, nanopublications could be
enhanced by using SEE as a model for representing evidence. Also, exploring links of
RDO constructs to upper-level ontologies such as SIO [39] or BFO [40] might be benefi-
cial for integration of SEE with other biomedical ontologies.
Claims made in scientific research communications are usually embedded in a contex-
tually and rhetorically rich narrative and attenuated by expressions of epistemic modality
[41]. Adding such assertions of certainty to the representation will be an important exten-
sion of the SEE approach. Likewise, definition of domain- and application-specific patterns
of relevant claims and arguments will be of great value for streamlining the generation of
formalized evidence accounts as well as for leveraging text mining approaches for compu-
tational identification and extraction of claim subjects and argumentative structure.
Conclusions
SEE (Semantic EvidencE) is an approach to represent scientific evidence in terms of
the argumentative structure of the supporting background. The presented case study
suggests that SEE is capable to provide a computationally accessible account of evi-
dence even in complex settings. SEE enables a coherent representation of evidence-
related information such as the materials, methods, assumptions, reasoning and infor-
mation sources used to establish a scientific finding by adopting a consistently claim-
based perspective on scientific results. SEE allows for extensible evidence representa-
tions, in which the level of detail can be chosen as needed and existing accounts can
be extended. Its design permits representation of arbitrary many layers of consecutive
interpretation and attribution as well as different evaluations of the same data. SEE is
specified as an RDF/OWL based approach for integration with other semantic web
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resources and linked open data environments but its underlying model can also be
used in other knowledge engineering and knowledge representation approaches.
Availability
Project website: http://purl.org/see.
The latest version of RDO can be accessed from the project website and directly at
http://www.purl.org/see/rdo.
Methods
Protégé 4 [42] was used as ontology engineering environment for developing and testing
RDO. Named graph representations were prepared according to the TriG specification
[21]. Resources used to represent the case study entities were defined in the http://purl.
org/see/gsexample# namespace to provide a homogeneous representation layer indepen-
dent of mappings to other ontologies or resources. Mappings of individual constructs to
other biomedical ontologies were researched using Ontobee [43] and are listed in addi-
tional file 4. Representation of biochemical entities (e.g. GS-enzyme, GS-activity) follows
the approach described in [44]. The representation of intermediate steps of the investiga-
tion described in Tate et al. [29] uses in part design patterns adapted from patterns origin-
ally specified for the Ontology for Biomedical Investigations (OBI) [45-47].
We have adopted the following nomenclature for labelling proposition and asser-
tion instances. Labels of proposition instances are derived from the labels of the
resources used in its associated graph representation and the type of axiom involved. For
restrictions, subclass axioms and type declarations the corresponding keywords of the Man-
chester OWL Syntax [48] are used. Proposition instances whose graph representation is
derived from formalizing a statement of the form “some A related to some B” i.e. consists of
the instantiation of a class (A and related_to some B) are alternatively labelled as
“some A related_to some B“. Assertion instance labels are specified on the basis of
the labels of corresponding proposition instances (linked via rdo:asserts) and
agents (linked via rdo:is_assertion_made_by). If “P” is the proposition label and “A”
is the agent label, the assertion is labelled as “! P ! A”. Multiple propositions are concate-
nated by “ AND “. Multiple agents are separated by a space symbol. For our case study,
author names are further abbreviated by their initials. The rationale of this nomenclature is
that it allows to quickly understand what is asserted and who asserts, maintains a clear con-
nection between assertion and proposition, maintains a connection to the formal represen-
tation of the assertion subject and singles out assertions as being labelled with a leading
exclamation mark.
Additional material
Additional file 1: rdo_owl.txt. Full, formal specification of all RDO constructs. This version is also available at
http://purl.org/see/rdo/1.0. The latest version of RDO is available at http://purl.org/see/rdo.
Additional file 2: gsexample_owl.txt. Representation of the argumentative structure and axioms involving the
entities used to model the case study in OWL format.
Additional file 3: gsexample_propositions_trig.txt. Named graph representations of assertion subjects.
Additional file 5: gsexample_sparql.txt. SPARQL queries for the case study representation.
Additional file 6: SEE_MP_comparison_note.pdf. A short comparison of central concepts in the SEE and MP
(Micropublications) models.
Additional file 4: mappings.pdf. Mappings of constructs in the case study representation to other biomedical
ontologies.
Bölling et al. Journal of Biomedical Semantics 2014, 5(Suppl 1):S1
http://www.jbiomedsem.com/content/5/S1/S1
Page 20 of 22
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CB and MW conceived the conceptual elements of the SEE approach and developed the abstract model underlying
the RDO. CB implemented the RDO in OWL, developed the design patterns and formulated the test case
representation with contributions by MW. CB, MW and HGH evaluated several development versions of the design
patterns and resulting representations. HGH supervised the research. CB drafted the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
We thank Andreas Hoppe and Matthias König for helpful discussions and input. We also thank two anonymous
reviewers for their comments which led to an improved presentation of this work. CB and MW were supported by
the German Federal Ministry of Education and Research (BMBF) within the Virtual Liver Network (grant numbers
0315756, 0315746). This work was conducted using the Protégé resource, which is supported by grant GM10331601
from the National Institute of General Medical Sciences of the United States National Institutes of Health.
Declarations
Publication of this article was funded by the Virtual Liver project of the German Federal Ministry of Education and
Research, grant no. 0315741.
This article has been published as part of Journal of Biomedical Semantics Volume 5 Supplement 1, 2014: Proceedings
of the Bio-Ontologies Special Interest Group 2013. The full contents of the supplement are available online at http://
www.jbiomedsem.com/supplements/5/S1.
Authors’ details
1Institute of Biochemistry, Charité Universitätsmedizin Berlin, Berlin, Germany. 2Department of Computer Science,
Humboldt-Universität zu Berlin, Berlin, Germany.
Published: 3 June 2014
References
1. Fernández-Suárez XM, Galperin MY: The 2013 Nucleic Acids Research Database Issue and the online molecular
biology database collection. Nucleic Acids Res 2013, 41:D1-D7.
2. Benson G: Editorial. Nucleic Acids Research 2013, 41:W1-W2.
3. Ruttenberg A, Clark T, Bug W, Samwald M, Bodenreider O, Chen H, Doherty D, Forsberg K, Gao Y, Kashyap V, et al:
Advancing translational research with the Semantic Web. BMC Bioinformatics 2007, 8(Suppl 3):S2.
4. Antezana E, Kuiper M, Mironov V: Biological knowledge management: the emerging role of the Semantic Web
technologies. Brief Bioinform 2009, 10:392-407.
5. Chen H, Yu T, Chen JY: Semantic Web meets Integrative Biology: a survey. Brief Bioinform 2013, 14:109-125.
6. Schreiber G, Raimond Y: RDF 1.1 Primer.[http://www.w3.org/TR/2014/NOTE-rdf11-primer-20140225/].
7. Callahan A, Cruz-Toledo J, Dumontier M: Ontology-Based Querying with Bio2RDF’s Linked Open Data. J Biomed
Semantics 2013, 4(Suppl 1):S1.
8. Willighagen EL, Waagmeester A, Spjuth O, Ansell P, Williams AJ, Tkachenko V, Hastings J, Chen B, Wild DJ: The ChEMBL
database as linked open data. J Cheminform 2013, 5:23.
9. Hitzler P, Krötzsch M, Parsia B, Patel-Schneider PF, Rudolph S: OWL 2 Web Ontology Language: Primer.[http://www.w3.
org/TR/owl2-primer/].
10. Smith B, Ashburner M, Rosse C, Bard J, Bug W, Ceusters W, Goldberg LJ, Eilbeck K, Ireland A, Mungall CJ, et al: The OBO
Foundry: coordinated evolution of ontologies to support biomedical data integration. Nat Biotechnol 2007,
25:1251-1255.
11. Luciano JS, Andersson B, Batchelor C, Bodenreider O, Clark T, Denney CK, Domarew C, Gambet T, Harland L, Jentzsch A,
et al: The Translational Medicine Ontology and Knowledge Base: driving personalized medicine by bridging the
gap between bench and bedside. J Biomed Semantics 2011, 2(Suppl 2):S1.
12. Whetzel PL: Powering semantically aware applications. J Biomed Semantics 2013, 4(Suppl 1):S8.
13. Callahan A, Dumontier M, Shah NH: HyQue: evaluating hypotheses using Semantic Web technologies. J Biomed
Semantics 2011, 2(Suppl 2):S3.
14. Soldatova LN, Rzhetsky A: Representation of research hypotheses. J Biomed Semantics 2011, 2(Suppl 2):S9.
15. Serafini L, Homola M: Contextualized knowledge repositories for the Semantic Web. Web Semantics: Science, Services
and Agents on the World Wide Web 2012, , 12-13: 64-87.
16. Ciccarese P, Wu E, Wong G, Ocana M, Kinoshita J, Ruttenberg A, Clark T: The SWAN biomedical discourse ontology.
J Biomed Inform 2008, 41:739-751.
17. Rahwan I, Banihashemi B: Arguments in OWL: A Progress Report. In Proceedings of the 2008 conference on
Computational Models of Argument (COMMA 2008); Amsterdam, The Netherlands IOS Press; 2008, 297-310.
18. Ciccarese P, Ocana M, Castro LJG, Das S, Clark T: An open annotation ontology for science on web 3.0. J Biomed
Semantics 2011, 2(Suppl 2):S4.
19. Ciccarese P, Ocana M, Clark T: Open semantic annotation of scientific publications using DOMEO. J Biomed
Semantics 2012, 3(Suppl 1):S1.
20. Gibson A, van Dam JCJ, Schultes EA, Roos M, Mons B: Towards Computational Evaluation of Evidence for Scientific
Assertions with Nanopublications and Cardinal Assertions. In Proceedings of the 5th International Workshop on
Semantic Web Applications and Tools for Life Sciences (SWAT4LS) Paris, France 2012, 28-30.
21. Carroll J, Bizer C, Hayes P, Stickler P: Named Graphs. Web Semantics: Science, Services and Agents on the World Wide
Web 2005, 3.
Bölling et al. Journal of Biomedical Semantics 2014, 5(Suppl 1):S1
http://www.jbiomedsem.com/content/5/S1/S1
Page 21 of 22
22. Textor M: States of Affairs. In The Stanford Encyclopedia of Philosophy Zalta EN 2012 [http://plato.stanford.edu/archives/
sum2012/entries/states-of-affairs/], Summer 2012 edition.
23. Achinstein P: The book ef evidence New York: Oxford University Press; 2001.
24. Pagin P: Assertion. In The Stanford Encyclopedia of Philosophy Zalta EN 2008 [http://plato.stanford.edu/archives/fall2008/
entries/assertion/], Fall 2008 edition.
25. McGrath M: Propositions. In The Stanford Encyclopedia of Philosophy Edited by Zalta EN 2012, Summer 2012 edition.
26. Gille C, Bölling C, Hoppe A, Bulik S, Hoffmann S, Hübner K, Karlstädt A, Ganeshan R, König M, Rother K, et al:
HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver
physiology. Mol Syst Biol 2010, 6:411.
27. Thiele I, Swainston N, Fleming RMT, Hoppe A, Sahoo S, Aurich MK, Haraldsdottir H, Mo ML, Rolfsson O, Stobbe MD,
et al: A community-driven global reconstruction of human metabolism. Nat Biotechnol 2013, 31:419-425.
28. Meister A: Glutamine synthetase from mammalian tissues. Methods Enzymol 1985, 113:185-199.
29. Tate SS, Leu FY, Meister A: Rat liver glutamine synthetase. Preparation, properties, and mechanism of inhibition by
carbamyl phosphate. J Biol Chem 1972, 247:5312-5321.
30. Schneider M, Carroll J, Herman I, Patel-Schneider PF: OWL 2 Web Ontology Language RDF-Based Semantics (Second
Edition).[http://www.w3.org/TR/2012/REC-owl2-rdf-based-semantics-20121211/].
31. Wellner VP, Meister A: Binding of adenosine triphosphate and adenosine diphosphate by glutamine synthetase.
Biochemistry 1966, 5:872-879.
32. SPARQL 1.1 Overview. The W3C SPARQL Working Group;[http://www.w3.org/TR/2013/REC-sparql11-overview-20130321/].
33. Brown J, Cappelen H: Assertion: new philosophical essays New York; Oxford: Oxford University Press; 2011.
34. Werlich E: A text grammar of English.Heidelberg: Quelle & Meyer 1983, 2 edn.
35. du Plessis L, Skunca N, Dessimoz C: The what, where, how and why of gene ontology–a primer for
bioinformaticians. Brief Bioinform 2011, 12:723-735.
36. Mons B, Velterop J: Nano-Publication in the e-science era. Proceedings of the Workshop on Semantic Web Applications
in Scientific Discourse (SWASD 2009), collocated with the 8th International Semantic Web Conference (ISWC-2009),
Washington DC, USA 2009.
37. Clark T, Ciccarese P, Goble CA: Micropublications: a Semantic Model for Claims, Evidence, Arguments and
Annotations in Biomedical Communications.[http://arxiv.org/abs/1305.3506].
38. Ciccarese P, Shotton D, Peroni S, Clark T: CiTO + SWAN: The Web Semantics of Bibliographic Records, Citations,
Evidence and Discourse Relationships. Semantic Web Journal: Interoperability, Usability, Applicability 2013.
39. Dumontier M, Baker CJO, Baran J, Callahan A, Chepelev L, Cruz-Toledo J, Del Rio NR, Duck G, Furlong LI, Keath N: The
Semanticscience Integrated Ontology (SIO) for biomedical research and knowledge discovery. J Biomed Semantics
2014, 5:14[http://www.jbiomedsem.com/content/5/1/14].
40. Grenon P, Smith B, Goldberg LJ: Biodynamic Ontology: Applying BFO in the biomedical domain. Pisanelli DM: IOS
Press 2004, 20-38.
41. de Waard A, Schneider J: Formalising Uncertainty: An Ontology of Reasoning, Certainty and Attribution (ORCA).
Proceedings of the Joint Workshop on Semantic Technologies Applied to Biomedical Informatics and Individualized Medicine
(SATBI+SWIM 2012), collocated with the International Semantic Web Conference (ISWC 2012), Boston MA, USA, October 11,
2012 2012.
42. The Protégé Ontology Editor and Knowledge Acquisition System. [http://protege.stanford.edu].
43. Xiang Z, Mungall C, Ruttenberg A, He Y: Ontobee: A Linked Data Server and Browser for Ontology Terms.
Proceedings of the 2nd International Conference on Biomedical Ontologies (ICBO); July 28-30 2011, 279-281.
44. Bölling C, Dumontier M, Weidlich M, Holzhütter H-G: Role-based representation and inference of biochemical
processes. Proceedings of the 3rd International Conference on Biomedical Ontology (ICBO 2012) Graz, Austria, July 21-25,
2012 2012 [http://ceur-ws.org/Vol-897/session3-paper14.pdf].
45. Brinkman RR, Courtot M, Derom D, Fostel JM, He Y, Lord P, Malone J, Parkinson H, Peters B, Rocca-Serra P, et al:
Modeling biomedical experimental processes with OBI. J Biomed Semantics 2010, 1(Suppl 1):S7.
46. OBI general model. [http://obi-ontology.org/page/Investigation].
47. OBI case study. [http://obi-ontology.org/page/Lauwereyns2002].
48. Horridge M, Patel-Schneider PF: OWL 2 Web Ontology Language Manchester Syntax (Second Edition).[http://www.
w3.org/TR/2012/NOTE-owl2-manchester-syntax-20121211].
doi:10.1186/2041-1480-5-S1-S1
Cite this article as: Bölling et al.: SEE: structured representation of scientific evidence in the biomedical domain
using Semantic Web techniques. Journal of Biomedical Semantics 2014 5(Suppl 1):S1.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Bölling et al. Journal of Biomedical Semantics 2014, 5(Suppl 1):S1
http://www.jbiomedsem.com/content/5/S1/S1
Page 22 of 22
